8/30/2006 - Glycemic Control
|
Issue |
Diabetes mellitus is a chronic condition associated with abnormally high levels of glucose in the blood whereas the body does not produce enough insulin or the insulin that is produced is ineffective. The blood sugar level may be monitored by the patient at various frequencies. The high blood glucose levels can sometimes be controlled with diet and exercise alone but may also require the use of insulin or other medications. The main goal of diabetes management is to control blood glucose levels and thereby to prevent the complications of diabetes. Diabetes when not well controlled is a leading cause of adult blindness, lower-limb amputation and kidney disease. The hemoglobin A1C test is a blood test that measures average blood glucose control over a three-month period that helps to identify longer-term trends in glucose levels and where adjustments in treatment are needed.
The MCAC will be reviewing evidence on:
(1) glycemic control using continuous glucose monitors;
(2) the relationship of outpatient glucose monitoring (type and frequency) to glycemic control and/or clinical outcomes in the various Medicare populations;
(3) the relationship of outpatient glycemic control to the clinical outcomes in the various Medicare populations;
(4) The linearity of the effects of glycemic control; and
(5) the relationship of increase hypoglycemic risk to glycemic control and/or clinical outcomes.
The clinical outcomes reviewed will include blunting the progression of disease, reversing diabetic complications, and altering morbidity/mortality in the Medicare populations.
The role of variables such as the type of diabetes, the therapeutic regimen employed, the age of hyperglycemic onset, the duration of diabetes, the duration of poor glycemic control, the level of hyperglycemia, and concomitant disease will be discussed.
In addition to evaluating the available data, the committee will identify areas in which the current data are deficient and in which additional research is warranted.
|
Actions Taken |
|
|
July 10, 2006 |
FR Notice [PDF, 76KB] Posted announcing MCAC for August 30, 2006 |
July 17, 2006 |
Posted questions [PDF, 116KB] to panel. |
August 25, 2006 |
Posted MCAC questions updated [PDF, 138KB] to panel. |
August 29, 2006 |
Posted agenda and roster. |
August 30, 2006 |
Posted technology assessment. |
August 31, 2006 |
Posted voting results [PDF, 222KB]. Please note there are 2 worksheets within the file: one for question 1 & one for questions 2-7. |
November 17, 2006 |
Posted minutes [PDF, 1MB], transcript [PDF, 608KB], and presentations [ZIP, 775KB]: "Diabetes Considerations from a Medicare Contractor" and "Background Material". |
| Federal Register Notice |
Agenda |
Medicare Coverage Advisory Committee
August 30, 2006
7:30 AM – 4:30 PM
CMS Auditorium
Agenda
Alan M. Garber, MD, PhD, Chairperson
Alex Krist, MD, Vice-Chairperson
Steve Phurrough, MD, MPA, Coverage and Analysis Group
Michelle Atkinson, Executive Secretary
|
|
7:30 – 8:00 AM |
Registration |
8:00 – 8:10 AM |
Opening Remarks—M. Atkinson / S. Phurrough, MD, MPA/Alan Garber, MD, PhD |
8:10 8:30 AM |
CMS Presentation of Voting Questions and Clinical Background:
Sandra Jones, RN, Elizabeth Koller, MD, FACE |
8:3 0 – 8:50 AM |
DMERC- Arthur Lervey, MD |
8:50 – 9:00AM |
Presentation of the TA: Ethan Balk, MD MPH, Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center |
9:00 – 11: 30 AM |
Presentations ( Refer to Presenter List) |
11:30PM – 12:30PM |
Scheduled Public Comments
(Refer to Speaker List) |
Public attendees, who have contacted the executive secretary prior to the meeting, will address the panel and present information relevant to the agenda. Speakers are asked to state whether or not they have any financial involvement with manufacturers of any products being discussed or with their competitors and who funded their travel to this meeting. |
12:30 – 1:00 PM |
LUNCH (on your own) |
1:00 – 1:30 PM |
Open Public Comments
Public Attendees who wish to address the panel will be given that opportunity |
1:3 0 – 2:30 PM |
Questions to Presenters |
2:30 – 3:30 PM |
Open Panel Deliberations: Dr. Garber |
3:30 – 4:25 PM |
Formal Remarks and Vote
The Chairperson will ask each panel member to state his or her position on the voting questions |
4:25 – 4:30 PM |
Closing Remarks / Adjournment: Dr. Phurrough, Dr. Garber |
4:30 PM |
ADJOURN |
|
Minutes |
Download Minutes [PDF, 1MB].
| Transcript |
Panel Voting Questions |
Download MCAC Updated Questions [PDF, 138KB].
Download voting results [PDF, 222KB].
|
Contact Information |
Betty Shaw, RN, CDR USPHS | Sandra Jones, RN sandra.jonesd@cms.hhs.gov 1-410-786-2273
| Presentations |
Roster |
|
|
Alan M. Garber, MD, PhD (Chair)
Director, Center for Primary Care and Outcomes Research
Stanford University
Stanford, CA |
Consumer Representative
Charles J. Queenan, III
Independent Management Consultant
McLean, VA
|
Alexander H. Krist, MD (Vice-Chair)
Department of Family Medicine
Virginia Commonwealth University
Richmond, VA
|
Industry Representative
Donald W. Rucker MD
Siemens Medical Solutions
Malvern, PA
|
Edgar Black, MD
BlueCross BlueShield Association
Chicago, IL |
Guest Panel Experts
Rodney A. Hayward, MD
Director, VA Ann Arbor Health Services Research & Development Center of Excellence
Professor, Departments of Internal Medicine and Health Management & Policy
Director, Measurement Core, Michigan Diabetes Research & Training Center
Co- Director, RWJ Clinical Scholars Program
Ann Arbor, MI
|
Douglas D. Bradham, Dr. PH
Director, Health Services Research and Development Center
Baltimore, MD
|
Mark E. Molich, MD
Professor of Medicine
Northwestern University
Feinberg School of Medicine
Section of Endocrinology
Chicago, IL
|
Margaret A. Piper, PhD, MPH
Senior Consultant
Technology Evaluation Center,
BlueCross BlueShield Association
Atlanta, GA |
Gayle E. Reiber, PhD, MPH
Research Career Scientist, VA Puget Sound Health Care System,
Professor of Health Services and Professor of Epidemiology
University of Washington
Department of Health Services
Seattle, WA |
James E. Puklin, MD
Professor of Ophthalmology
Wayne State University, School of Medicine
Kresge Eye Institute
Detroit, MI |
|
Jonathan P. Weiner, PhD
Professor & Deputy Director
Health Services Research & Development Center
The Johns Hopkins University
Bloomberg School of Public Health
Baltimore, MD
|
|
Harry B. Burke, MD, PhD
Associate Professor of Medicine
George Washington University School of Medicine
Washington, DC
|
|
A. Mark Fendrick, MD
The University of Michigan
Ann Arbor, MI |
|
|
|
|
Add to basket
|
Email this to a friend
|
New Search
Page Last Modified: 11/14/2008 11:15:46 AM
Help with File Formats and Plug-Ins
Submit Feedback
|